A Comparative Study of Prophylactic Anticoagulation in Meningioma Surgery
- Registration Number
- NCT01941602
- Lead Sponsor
- St. Olavs Hospital
- Brief Summary
The aim of the study is to compare different strategies for prevention of venous thromboembolism related to intracranial meningioma surgery. The investigators identified three hospitals where two have a very restrictive approach with respect to anticoagulant therapy while at the third hospital the use of anticoagulation the day before surgery was initiated as routine prophylaxis.
Based on this "natural experiment" it will be explored whether the use of anticoagulant prophylaxis is associated with reduced risk of venous thromboembolism and/or associated with increased risk of postoperative hemorrhage as compared to the 2 cohorts where this intervention were absent.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 979
- First included patient 1.january 2007 and latest included patient 1.july 2013 (allows for 30 day follow up with respect to morbidity)
- Histological verification of a meningioma (of any grade) from the current surgery
- Intracranial surgery or venous thromboembolism the last 3 months
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description prophylactic prophylactic enoxaparin Prophylactic treatment with drugs to prevent venous thromboembolism in patients operated with open surgery for intracranial meningioma at the Department of neurosurgery at Karolinska Hospital, Stockholm, Sweden non-prophylactic non-prophylactic No use of prophylactic treatment with drugs to prevent venous thromboembolism in patients operated with open surgery for intracranial meningioma at the Departments of neurosurgery at University Hospital North Norway (UNN) and St.Olavs University Hospital (Tromsø and Trondheim respectively, both Norway)
- Primary Outcome Measures
Name Time Method frequencies of venous thromboembolism 30 days
- Secondary Outcome Measures
Name Time Method frequencies of hematomas in need of reoperation or that significantly alters subsequent care 30 days frequencies of hematomas in need of reoperation or that significantly alters subsequent care (e.g. intensive care unit or other intensified treatment based on postoperative intracranial hemorrhage)
Trial Locations
- Locations (3)
Karolinska University Hospital
🇸🇪Stockholm, Sweden
University Hospital of North Norway
🇳🇴Tromsø, Norway
St Olavs Hospital
🇳🇴Trondheim, Norway